Anglo-Swedish drugmaker AstraZeneca <a href="https://www.reuters.com/markets/companies/AZN.L" target="_blank">(AZN.L)</a> has signed a deal worth up to $247 million with U.S. artificial intelligence (AI) biologics firm Absci <a href="https://www.reuters.com/m…